Skip to content
Dx

ICD-10-PCS 2027 procedure code

3E074GCIntroduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Endoscopic Approach

✓ Valid for 2027

Short description: Introduce Oth Therap Subst in Coronary Art, Perc Endo

Code last changed in FY2018 (effective October 1, 2017). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About 3E074GC

3E074GC is the ICD-10-PCS code for a introduction procedure on the coronary artery using a percutaneous endoscopic approach with other therapeutic substance (qualifier: other substance). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

In plain terms, this corresponds to injection of therapeutic substance into heart, the ICD-9-CM procedure title it maps to (37.92).

For a different body part, codes include 3E084GC (heart), 3E0E4GC (products of conception), 3E0F4GC (respiratory tract), 3E0G4GC (upper GI), 3E0H4GC (lower GI), 3E0J4GC (biliary and pancreatic tract) and 8 more.

The same procedure with a different approach is coded 3E070GC (open) and 3E073GC (percutaneous).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2018, effective October 1, 2017.

What each character means

1. Section
3Administration
2. Body System
EPhysiological Systems and Anatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body System / Region
7Coronary Artery
5. Approach
4Percutaneous Endoscopic

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach and visualize the site of the procedure

6. Substance
GOther Therapeutic Substance

Includes: Anacaulase-bcdb; Bromelain-enriched Proteolytic Enzyme; Collagenase SANTYL Ointment; COSELA(tm) (Trilaciclib); ENSPRYNG(tm) (Satralizumab-mwge); Fostamatinib; Idarucizumab, Pradaxa(R)(dabigatran) reversal agent; NexoBrid(tm); Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent; SANTYL Ointment; Satralizumab-mwge; TAVALISSE(R); Trilaciclib

7. Qualifier
COther Substance

Other versions of this procedure

ICD-9-CM equivalent

Converter →
  • 37.92Injection of therapeutic substance into heartapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2018 (effective 10/1/2017): Added
  • No changes since FY2018.

Common questions about 3E074GC

Is 3E074GC a valid ICD-10-PCS code for 2027?

Yes. 3E074GC is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

What is the ICD-9 procedure code for 3E074GC?

The CMS GEMs map 3E074GC to ICD-9-CM 37.92 (Injection of therapeutic substance into heart).